Dr. Kolb treats patients with Interstitial Lung Diseases (ILD) in his specialty clinic, as well as practises General Respirology at St. Joseph’s Healthcare Hamilton. His research focuses on mechanisms of lung injury, repair and fibrosis, particularly in IPF. He conducts pre-clinical studies of disease mechanisms and efficacy of novel drugs. Dr. Kolb leads activities in biomarker development for lung fibrosis and serves as Principal Investigator and Steering Committee member in international and national ILD clinical trials. He has published over 300 peer-reviewed articles and received awards from the Parker B. Francis Families Foundation, Canadian Institute for Health Research and the National Institute for Health, amongst others. He is immediate past Chief Editor for the European Respiratory Journal, now Section Editor for ILD. The ERJ is one of the top journals in respiratory medicine with an impact factor of 24.9.